UNITED LAB News

UNITED LAB: VOLUNTARY ANNOUNCEMENTACQUISITION OF AWARD SHARES

Nov 7 05:31 ET

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2024

Nov 6 08:01 ET

UNITED LAB: THE GROUP'S PRODUCT CEFTAZIDIME FOR INJECTION PASSED THE CONSISTENCY EVALUATION

Oct 25 07:52 ET

UNITED LAB: THE GROUP'S PRODUCT AMOXICILLIN GRANULES PASSED THE CONSISTENCY EVALUATION

Oct 16 10:40 ET

UNITED LAB: UPDATED INFORMATION ON THE GROUP'S PRODUCT INSULIN DEGLUDEC INJECTION

Oct 14 06:40 ET

UNITED LAB: PROGRESS IN CLINICAL TRIAL OF THE GROUP'S PRODUCT TUL12101 EYE DROPS

Oct 14 06:22 ET

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2024

Oct 2 10:33 ET

UNITED LAB: Notification Letter with Reply Form to Non-registered Holder

Sep 27 09:12 ET

UNITED LAB: Notification Letter with Reply Form to Shareholders

Sep 27 09:08 ET

UNITED LAB: 2024 INTERIM REPORT

Sep 27 08:35 ET

UNITED LAB: SUPPLEMENTAL ANNOUNCEMENTTHE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2023

Sep 25 09:18 ET

UNITED LAB: Interim dividend for the six months ended 30 June 2024

Sep 25 08:55 ET

UNITED LAB: PAYMENT OF 2024 INTERIM DIVIDEND

Sep 25 08:50 ET

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024

Sep 4 09:44 ET

UNITED LAB: Interim dividend for the six months ended 30 June 2024

Aug 30 00:01 ET

UNITED LAB: Interim Results Announcement for the six months ended 30 June 2024

Aug 29 10:54 ET

UNITED LAB: POSITIVE PROFIT ALERT

Aug 15 10:22 ET

UNITED LAB: DATE OF BOARD MEETING

Aug 15 00:08 ET

UNITED LAB: PROGRESS IN CLINICAL TRIAL OF THE GROUP'S PRODUCT UBT251 INJECTION

Aug 12 09:41 ET

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2024

Aug 1 23:23 ET